4.8 Article

Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated Autoimmunity

Journal

IMMUNITY
Volume 35, Issue 5, Pages 832-844

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2011.09.015

Keywords

-

Categories

Funding

  1. ERC [233074]
  2. DFG [754-2-3]
  3. SFB 938-project
  4. Medical Faculty Ulm [ETH 0-20400-07, R01 AR055271]
  5. European Research Council (ERC) [233074] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Immunological functions of mast cells remain poorly understood. Studies in Kit mutant mice suggest key roles for mast cells in certain antibody- and T cell-mediated autoimmune diseases. However, Kit mutations affect multiple cell types of both immune and nonimmune origin. Here, we show that targeted insertion of Cre-recombinase into the mast cell carboxypeptidase A3 locus deleted mast cells in connective and mucosal tissues by a genotoxic Trp53-dependent mechanism. Ore-mediated mast cell eradication (Ore-Master) mice had, with the exception of a lack of mast cells and reduced basophils, a normal immune system. Ore-Master mice were refractory to IgE-mediated anaphylaxis, and this defect was rescued by mast cell reconstitution. This mast cell-deficient strain was fully susceptible to antibody-induced autoimmune arthritis and to experimental autoimmune encephalomyelitis. Differences comparing Kit mutant mast cell deficiency models to selectively mast cell-deficient mice call for a systematic re-evaluation of immunological functions of mast cells beyond allergy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available